Cargando…
The prostaglandin receptor EP2 determines prognosis in EP3-negative and galectin-3-high cervical cancer cases
Recently our study identified EP3 receptor and galectin-3 as prognosticators of cervical cancer. The aim of the present study was the analysis of EP2 as a novel marker and its association to EP3, galectin-3, clinical pathological parameters and the overall survival rate of cervical cancer patients....
Autores principales: | Dietlmeier, Sebastian, Ye, Yao, Kuhn, Christina, Vattai, Aurelia, Vilsmaier, Theresa, Schröder, Lennard, Kost, Bernd P., Gallwas, Julia, Jeschke, Udo, Mahner, Sven, Heidegger, Helene Hildegard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6981231/ https://www.ncbi.nlm.nih.gov/pubmed/31980713 http://dx.doi.org/10.1038/s41598-020-58095-3 |
Ejemplares similares
-
The Prostaglandin EP3 Receptor Is an Independent Negative Prognostic Factor for Cervical Cancer Patients
por: Heidegger, Helene, et al.
Publicado: (2017) -
Prostaglandin E2 receptor EP1 expression in vulvar cancer
por: Buchholz, Anna, et al.
Publicado: (2022) -
EP4 as a Negative Prognostic Factor in Patients with Vulvar Cancer
por: Buchholz, Anna, et al.
Publicado: (2021) -
Prostaglandin E2 receptor 3 (EP3) signaling promotes migration of cervical cancer via urokinase-type plasminogen activator receptor (uPAR)
por: Ye, Yao, et al.
Publicado: (2020) -
The role of EP-2 receptor expression in cervical intraepithelial neoplasia
por: Schmoeckel, Elisa, et al.
Publicado: (2020)